Y-mAbs Therapeutics
YMAB
$15.50
Share price
5.37%
Change (1 day)
151.22%
Change (1 year)
Categories
Y-mAbs Therapeutics (YMAB) - Total liabilities
Total liabilities on the balance sheet as of December 2023 : $26.88 M
According to Y-mAbs Therapeutics 's latest financial reports the company's total liabilities are $26.88 M. A company’s total liabilities is the sum of all current and non-current debts and obligations.
Y-mAbs Therapeutics - Total liabilities on balance sheet (from 2017 to 2023)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2023-12-31 | $26.88 M | -16.6% |
| 2022-12-31 | $32.23 M | -1.35% |
| 2021-12-31 | $32.67 M | 24.67% |
| 2020-12-31 | $26.21 M | 50.09% |
| 2019-12-31 | $17.46 M | 53.22% |
| 2018-12-31 | $11.39 M | 14.26% |
| 2017-12-31 | $9.97 M | 91.83% |
| 2016-12-31 | $5.2 M |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | $27.91 M | 3.85% | 🇺🇸 USA |